Objectives: This study describes the perspective of patients, nurses, pharmacists, doctors and policy makers to identify the level of collaboration and the areas for improvement to achieve inter-professional collaboration between doctors, nurses, pharmacists and policy makers in a primary care clinic. Methods: Patients (n ¼ 20), Nurses (n ¼ 10), pharmacists (n ¼ 11), doctors (n ¼ 10) and policy makers (n ¼ 5) from a primary care were individually interviewed using a semi-structured topic guide. Purposive sampling was used. Interviews were transcribed verbatim and analysed using thematic analysis informed by constant comparison. Results: Patients, doctors, nurses, pharmacists and policy makers were eager for pharmacists to be more proactive in creating health awareness and conducting osteoporosis screening at the primary care clinic via inter-professional collaboration. These findings were further examined using the D'Amour's structural model of collaboration which encompasses four main themes: shared goals and visions, internalization, formalization and governance. This model supports our data which highlights a lack of understanding of the pharmacists' role among the doctors, nurses, policy makers and pharmacists themselves. There is also a lack of governance and formalization, that fosters consensus, leadership, protocol and information exchange. Nonetheless, the stakeholders trust that pharmacists have sufficient knowledge to contribute to the screening of osteoporosis. Our primary care clinic can be described as developing towards an inter-professional collaboration in managing osteoporosis but is still in its early stages. Conclusions: Inter-professional collaboration in osteoporosis management at the primary care level is beginning to be practised. Efforts extending to awareness and acceptance towards the pharmacists' role will be crucial for a successful change.
Introduction
Healthcare systems are constantly seeking a more effective delivery of accessible, continuous and comprehensive services. 1 Patients have complex health needs and generally require more than one healthcare professional to address their health status. 2 Healthcare professionals are thus confronted with the need for inter-professional collaboration (IPC). The World Health Organization defines IPC as 'multiple health workers from different professional backgrounds working together with patients, families, carers and communities to deliver the highest quality of care.' 3 It is a partnership between a team of health providers and a person in a participatory collaborative and coordinated approach to shared decision making around health and social issues. 4 Other aspects of IPC involves responsibility, accountability, cooperation, mutual trust, respect, communication and decision making, enabling a synergistic influence of group knowledge and skills. 5 Evidence demonstrates that an effective collaborative practice optimizes health services, strengthens health systems and improves health outcomes.
6e9 IPC has been shown to be effective in implementing multidisciplinary strategies for the management of heart failure patients 8 and implementing total parenteral nutrition teams within a hospital. 9 Furthermore, the introduction of collaborative practice in the health system has reduced the cost of setting up and implementing primary care teams for elderly patients with chronic illnesses. 10 Patients also report higher levels of satisfaction, better acceptance of care and improved health outcomes following treatment by a collaborative team in both acute and primary care setting. 11 As such, a study by Nies et al. 12 highlights that IPC gives rise to patient-centred actions. 12 Literature has shown that the inclusion of pharmacists into healthcare delivery teams improves health outcomes in various areas such as diabetes, 13 osteoporosis, 14 and asthma. 15 Pharmacists are most often associated with the dispensing of medication. However, in recent years, the role of the pharmacist has evolved from a product-centred approach (as purchasers of medications) to a more patient-oriented approach (the provision of pharmaceutical care). 16 There is therefore a need to build a collaborative working relationship between pharmacists and other healthcare professionals, as pharmacists play a critical role as a member of the integrated healthcare provider team. 16e18 In Canada, the National Association of Pharmacy Regulatory Association includes professional collaboration and teamwork in its professional competencies for pharmacists. 19 This change in practice has resulted in an increased interest to examine IPC with the pharmacist in the healthcare setting.
20e22
Another study showed that inpatients admitted to a team-based care system (which included the clinical pharmacist working with doctors and nurses) improved the overall quality of medication use and reduced rates of admissions. 20 In the United Kingdom (UK), a study highlighted the dynamic nature of the relationship between community pharmacists and general practitioners. They noted that some of the important qualities for IPC were trust, communication, respect and understanding each profession's roles and responsibilities. 21 Liu et al. 22 noted that different factors were associated with collaborative care at different study times, and demonstrated that trust and role specification were important factors for IPC at baseline. They noticed that after three months, trust and professional interactions became the most important factors influencing IPC. 22 In Malaysia, primary care services comprise of private general practices, government primary care clinics in the community, and government primary care clinics located within teaching hospitals. All three practices manage both acute and chronic conditions. This study was conducted in a government primary care clinic located within a teaching hospital. Malaysia has not achieved dispensing separation. This means that general practitioners can dispense medications from their clinic, but patients would have to pay the full cost of their medications. However, in government clinics where the cost of healthcare and medications are heavily subsidized, medications are dispensed by pharmacists. Government employees and retirees are entitled to free healthcare and medications at government hospitals, whilst others pay a nominal sum of less than $10 for consultation and medications. The role of the pharmacist in providing pharmaceutical care for ambulatory patients is minimal.
To date, no study has analysed factors influencing IPC between pharmacists, doctors, policy makers and nurses at the primary care level. It is important therefore to explore and understand the areas that need improvement and to customize interventions to the specific collaboration stage to achieve IPC. 22 As such, qualitative methods were used with guidance from the D'Amour model to explore and understand areas of IPC and to customize the intervention to the specific collaboration stage. The D'Amour model was selected as it can be used to analyse the complex and heterogeneous multi-level systems of personnel collaborating in the primary care clinic to determine the level of IPC and to identify areas that require improvement. 1 Therefore, the study aimed to identify the level of collaboration, and the areas that require improvement, in order to achieve IPC in a primary care clinic.
Methods
Qualitative, semi-structured in-depth interviews were used to identify the level of collaboration and the areas for improvement to achieve IPC with pharmacists in a primary care clinic. A qualitative methodology was used as it allowed for detailed exploration of the experiences and views of stakeholders such as patients, nurses, doctors, pharmacists and policy makers concerning IPC and the pharmacists. Prior to commencement of the interviews, ethical approval was obtained from the University Malaya Medical Centre Ethics Committee (approval number: 914.14).
Setting
The study was conducted at the primary care clinics located within a teaching hospital in Malaysia.
Participants and sampling

Patients
Purposive sampling was used to select non-osteoporotic postmenopausal women 50 years of age from three main ethnics groups (Malays, Chinese, and Indians) in Malaysia. to account for any cultural differences. Initially, it was not intended to recruit patients using the snowballing method. However, many patients of Malay ethnicity declined participation. Therefore, in order to gain access to Malay patients, we employed the snowballing method. Participants with a history of metabolic disease, presence of bone metastasis, significant renal impairment, previous bilateral oophorectomy, previous hip fracture or prior use of any bisphosphonates were excluded from the study.
Nurses
Registered nurses (defined as nurses registered with the Nursing Board of Malaysia and have at least a diploma or degree in nursing) with more than one year of working experience in the primary care clinic were purposively selected. These nurses were selected as one of their roles is to screen patients at the triage counter, and therefore would have sufficient working experience and understanding of the primary care clinic's barriers, facilitators and management issues. Nurses from other departments were excluded.
Doctors
Similarly, medical officers and family medicine trainee doctors with more than one year of working experience in the primary care clinic were selected using purposive sampling. They were interviewed as they were involved in the treatment of patients with osteoporosis.
Pharmacists
Pharmacists were also selected using purposive sampling. Pharmacists who had at least one year of working experience in the outpatient pharmacy were recruited. Intern pharmacists were excluded as they were not in a position to make any decisions regarding pharmacy practice. Pharmacists were interviewed we wanted to explore the expansion of the pharmacists' role to include osteoporosis screening.
Policy makers
Policy makers were defined as individuals who had the authority to influence practice. The Head of Primary Care Department was included as her view represented the management of primary care doctors. The Heads of outpatient pharmacy, pharmacy store, in-patient pharmacy, as well as the chief pharmacist were also included, as they were all involved in the development and administration of pharmacy services. However, the head of nursing, the Chief Executive Officer (CEO0 of the hospital and deputy CEO did not respond to the invitation to participate in this study.
Instruments used
Baseline demographic form
This form was used to collect patients' medical history, lifestyle and medication history. A separate baseline demographic information was used to collect information from healthcare professionals (nurses, doctors, pharmacists and policy makers) regarding their work experience and level of education.
Topic guide
Three topic guides were developed: one for patients, one for healthcare professionals (nurses, pharmacists, doctors) and one for policy makers. All three topic guides explored the stakeholders' knowledge, feelings and attitudes towards the roles of healthcare professionals (doctors, pharmacists and nurses) in the primary care clinic regarding a pharmacist-led osteoporosis screening program. Topic guides were developed based on literature, as well as discussion with an expert panel (consisting of a consultant endocrinologist and four pharmacists with many years of research and clinical experience). A pilot test was then conducted with three individuals (one for each topic guide) to finalise the topic guide.
Translation of the topic guide for patients and healthcare professionals (nurses, pharmacists, doctors) to Malay were performed as some interviews were conducted in Malay. Forward translation of the topic guide from English to Malay, was performed by a pharmacist who was a native Malay speaker. Backward translation (from Malay to English) was performed by another pharmacist who was bilingual in both English and Malay. Both pharmacists were not participants of this study. Differences were discussed by the expert panel until a final Malay version was developed.
Procedure
The researcher recruited patients by approaching them personally at the primary care clinic. Purposive sampling was used to ensure maximal variation was achieved. Patients were recruited while they were waiting for their doctors' appointment. Patients' medical records were screened to confirm that they did not have osteoporosis/osteopenia. The purpose of the study was explained to participants using a printed participant information sheet. Upon agreement to participate in the study, written informed consent was obtained. Participants were asked to fill the baseline demographic data form.
Data collection occurred from October 2012 to January 2013. Patients were interviewed in a quiet location (e.g. an unused doctor's room, conference room or seminar room) that was suitable for an interview within the clinic setting or at their homes. Although interviews were conducted in a number of different locations, it is believed that the change in setting would not have an impact on the quality of the interview itself (and the results) as the interviews were conducted in an environment which was quiet and private.
All interviews were conducted by a trained researcher in either English or Malay. Each interview lasted an average of 60 min. All interviews were transcribed verbatim. The first ten recorded interviews were transcribed by the researcher. Subsequent recordings were transcribed by undergraduate science students or pharmacists. In order to ensure that the data was rigorous and trustworthy, the transcripts performed by the researcher were checked by another pharmacist who was fluent in both languages. The transcripts performed by others were checked by the researcher for accuracy and completeness. All transcripts were offered to each interviewee to check for accuracy but all declined.
Data analysis
The analysis method used was thematic analysis. 23, 24 It involved repeatedly reading the transcripts while listening to the audio recording. Emerging topics were coded and constantly compared and contrasted with other transcripts.
23
QSR International Pty Ltd. NVivo version 10 for Windows, 2012 was used to aid in the analysis of the data. Analysis began during data collection. At the end of each interview, the researcher wrote memos of interesting topics that were raised during the interview. Data analysis was divided into two phases to ensure rigour. It began with a data-driven analysis, followed by a theory driven approach. While the latter approach ensures that the themes identified from the results were focused on the study aims, it can restrict new themes emerging. Hence, for the purpose of this study the theory driven approach was used to confirm the themes identified by the data driven approach. The study did not aim to build a theory nor to test a hypothesis. It was to identify the level of collaboration and the areas that required improvement to achieve IPC with pharmacists within a primary care clinic.
Phase 1, a data-driven approach
Codes were generated inductively from the data collected. 24, 25 The data-driven approach minimized bias when the codes and themes were identified. Coding was performed by one researcher who attended a qualitative workshop on how to analyse data, in consultation with two experienced qualitative researchers. Undergraduate students were not involved in the coding. Transcripts were read line by line and considered as a whole in order to identify key ideas which are called key nodes. 26 A coding framework was developed using the identified nodes. This framework was used for coding subsequent data. Newly identified codes were added to the coding framework. The whole process was iterative and involved rereading, linking and connecting text to the represented nodes. A second reviewer reviewed the initial coding alongside the original transcripts and any discrepancies were resolved via consensus. Subsequently, the data-driven analysis was refocused at a broader level of themes. 23 This involved sorting the themes into broader themes and collating all the relevant coded data extracts within the identified theme. The 'one sheet of paper' (OSOP) analysis as described by Ziebland and McPherson (2006) was used to progress the analysis of the data. OSOP involved reading through each code and then noting on a piece of paper all issues that were raised and making connections between them. 27 This process allowed identification of deviant cases that did not fit into the emerging story. These deviant cases were then reanalyzed by going back to the transcripts to check if the deviant cases were truly deviant or were able to fit into the emerging story. Deviant cases were either recoded into available codes or were considered a theme on their own. 28 During these phase the tree nodes were arranged into parent nodes (themes) and child nodes (subthemes). 23 Data saturation was defined when no new codes could be generated from our data. 29 The analysis of each stakeholder:
patients, pharmacists, nurses, doctors and policy makers was conducted separately. However, the themes which emerged within each group were similar and the analyses of all the stakeholders were combined. A subset of transcripts was reviewed by two members of the research team for agreement of the codes and themes.
Phase 2, a theory driven approach
On completion of the data-driven analysis phase 2, a theorydriven approach was subsequently used by the researcher. The analysis was enriched by going back to the literature noting how other research and theories fitted and how it could further inform the analysis. 23 This approach allows the researcher to formulate a theory based on the anticipated results and then develop a provisional list or framework of codes following the anticipated results. 24, 25 Subsequently, transcripts were coded using these provisional codes, and additional codes were added if necessary. The theory-driven approach ensures that the codes and themes identified from the results were focused on the study's aims. However, this method may miss out certain themes which were not identified by the theory, restricting the breadth of the findings. Therefore, the purpose for using this approach was to confirm the themes identified by the data-driven approach. Themes and sub themes were further refined based on the D'Amour theory ( Table 1) . The theory driven analysis categorized the IPC into four interlinked domains: 1) Shared goals and visionswhich refers to existence of common or divergent goals among the healthcare teams; 2) Internalization-which refers to an awareness by the healthcare professionals of their interdependencies and mutual trust; 3) Formalization-which is the extent to which the procedures are documented; and 4) Governance-which refers to leadership that support collaboration. These domains formed the framework under which subsequent codes were categorized. Finally, the themes and sub themes were reviewed to ensure that they 'accurately' reflect the meaning evident in the data set as a whole. The end stage of the analysis involved a presentation of the summary of all the interviews to all researchers. The confirmation of the themes and matching of the transcribed quotes with the themes and sub-themes derived from the analysis was finalized using consensus validation.
All transcripts were translated to English for verification purposes. The original language was used during data analysis. Analyzing in the original language facilitated cross checking the data with the audio recordings. This reduced misinterpretation that may be caused by voice modulations of the participants. During data analysis, selected themes and sub-themes from Malay were translated to English. This repeat translation helped the researcher to reduce misinterpretation. The study by Chen & Boore 30 concurs that verbatim transcripts and data analysis can be conducted in the original language and only emergent concepts, themes and subthemes needed translation to English. 30 Sample size was determined by data saturation whereby interviews ceased when no new themes emerged from the interviews.
Theoretical framework: D'Amour model
There are ten indicators within the four interlinked domains of shared goals and vision, internalization, formalization and governance. The 10 indicators can be categorized to three levels representing the level of achievement of an indicator (Table 1) . Level three is called "active collaboration" which is the maximum level of achievement. It refers to a setting that has successfully established stable collaboration and is sustainable despite uncertainties in the health care system. Level two is called "developing collaboration". It is collaboration that is not stable and may still be subjected to reevaluation as a consensus has not been reached. Although progress on collaboration is being made, it would require more time to achieve an active collaboration. The minimum level of achievement is level one, which is called "potential/latent collaboration". This level refers to collaboration that does not yet exist or has been blocked by conflicts that are so serious that the system cannot move forward. Relative absence of any common infrastructure or mechanism for collecting or exchanging information
Results
A total of 56 participants were interviewed (patients ¼ 20, nurses ¼ 10, pharmacists ¼ 11, doctors ¼ 10 and policymakers ¼ 5). Each interview lasted an average of 60 min. The age of the patients interviewed were between 52 and 72 years, out of which six were Malay, six were Indians, and eight were Chinese. All nurses had four years or more of working experience. Pharmacists' work experience ranged from 2 to 4 years, whilst doctors' work experience ranged from 3 to 4 years.
Sixteen patients' interviews, two nurses' interviews, nine pharmacists' interviews, and four doctor interviews were conducted in English. Two patient interviews, eight nurses' interviews, two pharmacist interviews and five interviews with policy makers were conducted in both English and Malay. Two patient interviews were conducted solely in Malay.
The main themes emerged can be divided into four main interlinked domains operationalized by ten operators ( Table 1 ). The four domains were: shared goals and vision, internalization, formalization and governance. We further examined our data using D'Amour's structural model of collaboration. The Kiviat graph [ Fig. 1 ] provides a schematic view of collaboration in our setting. It demonstrates that, this model supports our data which highlights a lack of governance and formalization, that fosters consensus, leadership, protocol and information exchange. The Kiviat graph was developed based on a consensus reached from the themes that emerged from the data. Based on D'Amour's model, this primary care clinic can be described as developing towards an IPC in managing osteoporosis but still at its early stages.
Shared goals and vision
The shared goal and vision dimension can be subdivided to two indicators called goals, and client-centred orientation versus other allegiances. The analysis of the data showed that the patients and healthcare professional team (nurses, pharmacists, doctors, policy makers) had a common set of goals namely, to increase health awareness and to increase health screening such as osteoporosis screening.
Stakeholders were open to increase the public's awareness of osteoporosis, as well as awareness in other areas like hepatitis. The stakeholders were supportive in working more closely with pharmacists, suggesting that pharmacists conduct counselling, give lifestyle and preventive advice. In addition, they suggested that pharmacists could conduct health talks at the clinics to improve patients' awareness of osteoporosis.
"If the pharmacist wants to do some counselling …. want(s) to give a talk … want(s) to do a video … to create awareness among the public, among the patients who are here in the clinic. … most welcome to …. " (DR-9/F/30y)
The second goal was to increase osteoporosis screening. To attain this goal, stakeholders noted that the solution could be a pharmacist-led osteoporosis screening programme in collaboration with the doctors.
"I think probably the pharmacist can … detect the problem (osteoporosis) … then they can suggest to the physician that … the patient will benefit from the BMD (scan)."
The results for the shared goals and vision showed that the stakeholders had common goals centred on client needs. They were open to improve the healthcare system and the progression of the pharmacy profession to provide better quality services to patients. Therefore, these two indicators were achieved at level 3.
Internalization
Regarding the internalization dimension, there were two indicators namely mutual acquaintanceship and trust. The doctors, pharmacists, nurses, policy makers were not mutually acquainted with the pharmacists' role in all aspects. Additionally, policy makers questioned if the pharmacists themselves understood their own role. Hence, the policy makers, doctors, nurses and pharmacists did not understand the pharmacists' scope of practice. Below is a quote by a doctor reflecting her lack of awareness of a pharmacist's role in the clinic.
"I really (have) no idea what … (the pharmacist does) … (Laughs)." (DR-8/F/29y)
Although the mutual acquaintanceship was low at level 1, the indicator trust achieved a moderate level 2. Despite not fully understanding the role of the pharmacists, stakeholders believed that Fig. 1 . Kiviat graph lays out the schematic view of collaboration in the primary care setting. the pharmacist had the knowledge and capabilities to conduct osteoporosis screening. The quote below illustrates the trust that a patient has towards pharmacists.
"They (pharmacists) have learnt and … gone through courses … I would trust them." (PT-12/F/59y)" However, the impression of others was that pharmacists were unable to contribute in any manner with regards to osteoporosis screening, except in medication supply and its cost. The quote below states how one of the doctors felt about the pharmacist's role "I really don't have (any) idea what is the pharmacist patient relationship besides giving the medicine."
(DR-7/F/28y)
Governance
In relation to our governance, the data showed weak centrality (level 1).
Frontline healthcare professionals rely on the direction of policy makers on what activities should be conducted. There was a lack of directive from the upper management on osteoporosis screening.
"We must speak to the … osteoporosis specialist (policy maker), encourage them to have this type of campaign (osteoporosis screening) … Only these people … can start these campaigns."
(NUR-6/F/55y).
"It boils down to policy makers, what do they want us to do. Then we will do it."
(PHARM-11/F/28y) There was no data to support innovation (level 1). Stakeholders gave the impression that there was no expertise or funding to promote innovation in a collaborative manner. Leadership exist but is unfocused and has little impact (level 2). For example, upper management was seen to provide opportunities to the junior pharmacists to be innovative. However, the junior pharmacists had not been able to take up such opportunities.
"Our meeting … (we) talked about (the) pharmacists' role and responsibilities and issues related to it … we have to nurture them (young pharmacists) … But if they are not ready then it's going to be very difficult." (POL-3/M/57y) Connectivity was poor (level 1). Essentially, there was a lack of communication between both the doctors and nurses with the pharmacists. Some of the interviewed participants mentioned that they have never spoken to a pharmacist and that the interviewer was their first pharmacist encounter. Reasons identified were that pharmacists work mostly within the pharmacy area. They also were not integrated to participate in other hospital activities such as health awareness campaigns. "… Our pharmacists (are) 'lock(ed) up' (at the pharmacy)." (NUR-3/F/43y) A similar situation was noted by the patients, where there was minimum communication with the pharmacists. Communication was limited to the dispensing of medications. Some patients perceived the pharmacists as unapproachable as they were too busy.
"The pharmacist … I don't communicate with them, just by the numbers only, whatever … but the dispensing … is ok." (PT-18/F/57y)
Formalization
Analysis of the formalization dimension shows that there was no clear guideline pertaining to osteoporosis screening or protocol on the division of responsibilities between the healthcare professionals (level 1). Stakeholders mentioned that the guidelines were outdated. Protocols and directives on who should conduct screening were unavailable making healthcare professionals confused on what can be done. The channels for exchanging information were level 1 as there were separate divisional meetings. The meetings were held together with junior and senior staff. However, meetings were held within individual professions and not inter-professionally. Therefore, this only resolved issues within the pharmacy without helping IPC.
"Our meeting is professional … irrespective of grade (junior/ senior) … (we) talk about pharmacy role and responsibilities and issues related to it." (POL-3/M/57y)
Discussion
All stakeholders were eager for pharmacists to be more proactive in counselling patients, in creating awareness on osteoporosis and screening of osteoporosis, via IPC. Based on the D'Amour's model, this primary care clinic can be described as developing towards an IPC in managing osteoporosis but is still in its early stages. It achieved level 2 in the sense that it is evolving, but remains incomplete. Healthcare professionals had a high level of shared goals. However, there is room for improvement in the areas of internalization, governance and formalization.
To the best of the authors' knowledge, there are no previous studies that reported on the perceptions of patients, nurses, pharmacists, doctors and policymakers concerning the pharmacist's role in osteoporosis screening at the primary care setting. Although effective treatment of osteoporosis is available, only about 20% of patients with an osteoporotic fracture undergo a bone mineral density (BMD) scan to screen for osteoporosis. 31e33 This may be because osteoporosis is a silent disease that is not prioritized by patients and healthcare professionals. 34, 35 This may be why this study setting only achieved a level 2 (developing IPC) in managing osteoporosis. Nonetheless, studies have found that integrating pharmacists into osteoporosis management in primary care increases the number of patients starting on osteoporosis treatment, undergoing BMD scans, increasing calcium intake and reducing drug interactions.
14 Numerous studies reporting on community pharmacist perceptions of their role in osteoporosis screening concur with the study results presented here. A Canadian study published in 1996 using a mailed survey found that only a few pharmacists (28.2%) reported routinely conducting prevention activities. However, over 90% believed it is important to integrate prevention into practice. 36 Similarly, another Canadian web based survey reported that pharmacists spend most of their time on dispensing duties but over 60% believed that the time had come to expand their role in areas such as disease prevention and health promotion. 37 This shows that the progression of Malaysian pharmacists is similar to that of its overseas counterpart as the stakeholders were open to having Malaysian pharmacists expand their roles.
Various studies also concur that pharmacists are considered credible for counselling as they are more easily accessible to the patients. 38 They also have various knowledge and skills regarding many public health issues. [38] [39] [40] [41] [42] Additionally, a systematic review conducted on the beliefs and attitudes of pharmacists in relation to pharmaceutical public health showed that although most view public health services as an important part of their role, various organizational barriers (lack of time, integration, staff and trust) limit their involvement. 39, 40 Therefore, these results confirm that the profession largely accepts changing the role of pharmacists from traditional dispensing duties to include greater involvement in health promotion and prevention. Another interesting point is that perceptions of pharmacists have not changed much in more than 10 years. Although pharmacists largely believe that they should be doing more such as prevention and screening; minimal changes to the profession have occurred over the past 10 years. 39 Conversely, another survey where pharmacists were similarly questioned about public health issues, the majority of the respondents considered they should be involved in hypertension (82%), diabetes (76%) and smoking cessation (84%), only 44% and 34% thought the same for osteoporosis and risk of falls, respectively. These findings suggest that pharmacists may not regard osteoporosis and falls risk as being important. 34 Indeed, the stakeholders in this study admitted that osteoporosis is not a priority. Given the demonstrated benefits of greater involvement in the management of osteoporosis, better ways must be found to translate this evidence-based knowledge into the primary health care system. 43 Several studies have evaluated the effectiveness of primary care intervention to improve the management of osteoporosis. A recent meta-analysis showed that these interventions (targeting at-risk patients, primary care physician and community pharmacists) may improve the management of osteoporosis but improvements are often modest. 43 A Canadian study using self-administered questionnaires to community pharmacists and public health officers noted that although a majority of the pharmacists believed that they should be involved in osteoporosis screening (46.6%) and falls prevention (50.3%), only 17.4% of the pharmacies reported being involved in this activity. The barriers noted in this study were similar to the current study such as the lack of time (78.8%) and lack of coordination with other healthcare professionals (54.5%). 44 This suggests that the development of these interventions where health care professionals work as individual groups does not appear to be an efficient option to optimize health care. Therefore, the results of the present study provide important information on the development of osteoporosis care using IPC.
Research has shown that pharmacists can indeed improve the quality of health care delivery in areas such as improving prescribing, reducing healthcare utilization and medication costs and also contribute to clinical improvements in many chronic medication conditions such as cardiovascular and diabetes. 45e48 Even in the management of osteoporosis, integrating community pharmacists into osteoporosis management has resulted in an increase in bone mineral density scan and calcium intake. 14,49e54 Unfortunately, pharmacists are not well integrated into primary care practice. The areas for improvement based on the D'Amour model should be noted in order for an efficient osteoporosis screening programme to be established. At this point, internalization (mutual acquaintanceship and trust), governance (connectivity) and formalization (information exchange) may be addressed by conducting a pharmacist-led osteoporosis screening programme. A study conducted by Dolovich et al. 45 integrated the pharmacists into the primary care practice to prevent drug-related issues.
Feedback from the physicians were that they were able to recognize the benefits of working with pharmacists directly integrated into their practice. Physicians showed an improved perception and understanding towards the pharmacists' role. Pharmacists on the other hand recognized the need to improve their skills, be more proactive and improve communication with their fellow healthcare team members. 45 An osteoporosis screening programme will foster opportunities to address these issues.
Other areas for improvement include governance (centrality and support for innovation) and formalization (no clear guidelines). It is hoped that with the success of the programme it will render more centrality, support for innovation and a clear guideline on osteoporosis screening. This is known as the bottom-up approach which has been shown to be effective in a study where leaders and professionals developed interdependency, measured collective performances and communicated feedback. Such approach makes managers aware of the need for IPC. It helps facilitate leadership, increased transparency and collective control which benefits both patients and providers. 55 Given the increasing stress on the healthcare system due to an aging population and the consequent rise in the prevalence of osteoporosis, a more marked shift toward a wider public health role for pharmacists is indeed possible by incorporating IPC. A limitation of our study was that a majority of the policy makers interviewed were policy makers with a pharmacy background, as other policy makers (the matron, the CEO of the hospital and deputy CEO) declined participation. However, the themes that emerged from the non-pharmacy related policy makers (such as the head of primary care) were similar to the themes raised by the pharmacy related policy makers in pharmacy. As such, the data reached data saturation, and represented the themes for the policy maker group. It was not possible to conduct focus group discussions due to the hectic work hours of the pharmacists, nurses and policymakers. Future research should consider conducting focus group discussions as they have an advantage of exploring the dynamics of communication between research participants, and in this case interdisciplinary collaboration. 56, 57 Another limitation of this study was that interviews considered were only conducted in Malay or English (the two main languages spoken in Malaysia). Interviews were not conducted in Mandarin or Tamil, as those proficient in Mandarin or Tamil would also be able to speak in English of Malay. In addition, another limitation was that the data was not analysed independently by two researchers, or compared to ensure consistency in analysis. 57 Instead, sections of the coded transcripts were presented to two researchers on separate occasions to establish if other members of the research team agreed with the codes assigned. Qualitative methods were used and therefore the results reflected the local setting, and are not generalizable to other settings. However, this study has highlighted that the D'Amour model is useful to understand the level of IPC, as well as to identify areas that required improvement. In qualitative studies, the researchers who are responsible for data collection and analysis may influence the interpretation of the results. Hence, it is vital to declare the backgrounds of the research team, and acknowledge the ways (i.e. interpretation and research experience) that the researchers may influence the outcomes. In this study, all members of the research team were academic pharmacists or doctors, whose experience ranged from being a novice to an experienced qualitative researcher. Steps were taken to ensure the validity of the results. Two qualitative validity methods were used which were constant comparison and cumulative validity. 57, 58 Constant comparison played a major role in this study.
This involved looking at all interviews as a whole rather than fragmenting them. This allowed the researcher to identify unanticipated themes. 58 Another technique used in this study for the process of validation was cumulative validation which was the theory-driven analysis. The literature was used to demonstrate that the study findings were consistent with existing knowledge. As such, transcripts were re-read to verify inconsistency issues where necessary. Respondent validity was another method used. It allowed participants to read the data and analyse it as well as provide feedback on the researchers' interpretations of their response. All participants declined. This may be due to the low literacy levels of patients and the lack of time by both patients and healthcare professionals. The strength of this study lies in the fact that the sample encompassed all healthcare professionals involved in the primary care setting. Hence, we were able to gain an in-depth understanding of IPC from a wide range of perspectives.
Conclusion
The selected setting was developing towards IPC in the primary care level, but is still in its early stages. There is room for improvement in the areas of internalization, governance and formalization. Efforts extending to awareness and acceptance of the pharmacists' role will be crucial for a successful change. Although, IPC is currently incorporated into undergraduate courses, there should be more emphasis on the importance of expanding IPC's as a subject into the curriculum. This is because important changes cannot be envisioned without a real integration of community pharmacists into the public health primary care system.
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